Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
---|
09/03/2008 | EP1963282A1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs |
09/03/2008 | EP1963281A2 Heterocyclic derivatives as modulators of ion channels |
09/03/2008 | EP1962984A1 Process for the treatment of an aqueous mixture comprising a dipolar aprotic compound |
09/03/2008 | EP1343781B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
09/03/2008 | EP1121129B1 METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND ASSOCIATED COMBINATIONS |
09/03/2008 | CN101258134A 2-(4-oxo-4H-quinazolin-3-yl) acetamides and their use as vasopressin V3 antagonists |
09/03/2008 | CN101258133A Pyrimidine derivatives and their use as kcnq potassium channels openers |
09/03/2008 | CN101255155A Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
09/03/2008 | CN101255138A Quinazoline ketone anticoccidial medicament |
09/03/2008 | CN101255137A Method for synthesizing 2-methylmercapto group-4 ethyl formate pyrimidine |
09/03/2008 | CN101255125A Process for preparation of 2-alkoxy-6-(trifluoromethyl)pyrimidin-4-ol |
09/03/2008 | CN100415802C Novel polymers for use in optical devices |
09/03/2008 | CN100415748C A2B adenosine receptor antagonists |
09/03/2008 | CN100415744C 2-arylamino-pyrimidines for the treatment of GSK3-related disorders |
09/03/2008 | CN100415743C Derivatives of pyrimido [6.1-a] isoquinolin-4-one |
09/03/2008 | CN100415725C Pyrimidine compounds and their use |
09/03/2008 | CN100415724C Pyrimidine derivatives |
09/03/2008 | CN100415720C Quinoline derivative and quinazoline derivative, and medicinal composition containing the same |
09/03/2008 | CN100415718C CASPASE inhibitors and use thereof |
09/02/2008 | US7419984 for uses such as inhibiting the activity of lysophosphatidic acid acyltransferase beta and/or inhibiting the proliferation of a cell (e.g., tumor cell) |
09/02/2008 | US7419983 Gonadotropin-releasing hormone receptor antagonists and methods related thereto |
09/02/2008 | US7419966 Viricides; human t-cell leukemia, lymphoma virus |
09/02/2008 | CA2389333C Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
09/02/2008 | CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors |
08/28/2008 | WO2008103351A2 Heterocyclic aspartyl protease inhibitors |
08/28/2008 | WO2008102369A1 Novel polymorphs of erlotinib hydrochloride and method of preparation |
08/28/2008 | US20080207903 Hydroxy-3-methylglutaryl/3-/ coenzyme A reductase inhibitor; anticholesterol agents;dyslipidemia; chemical intermediate for rosuvastatin |
08/28/2008 | US20080207659 Inhibitors of phosphodiesterase type 4 |
08/28/2008 | US20080207655 Diaminopyrimidines as P2X3 and P2X2/3 modulators |
08/28/2008 | US20080207654 Therapy for circulatory diseases; metabolism disorders; central nervous system disorders; hypotensive agents; cardiovascular disorders; antidiabetic agents; Alzheimer's disease |
08/28/2008 | US20080207636 Using a benzmide compound; antidiabetic agents; obesity |
08/28/2008 | US20080207619 Diaminopyrimidines as P2X3 and P2X2/3 modulators |
08/28/2008 | US20080207614 Quinazoline derivatives for the treatment and prevention of diabetes and obesity |
08/28/2008 | US20080207608 Stroke; antiinflammatory agents; sepsis; allograft; transplant rejection; antitumor agents; liver disorders; brain hemorrage; neurodegenerative diseases ; vision defects |
08/28/2008 | US20080207607 Antiarthritic agents; antiinflammatory agents; arteriosclerosis; multiple sclerosis |
08/28/2008 | US20080207606 Immunology diseases; analgesics; antiarthritic agents; cardiovascular disorders; antiischemic agents; skin disorders;antiulcer agents; bone disorders; antihistamines |
08/28/2008 | US20080207590 Inhibitors of Histone Deacetylase |
08/28/2008 | US20080206257 Reducing epithelial toxicity during cancer therapy by administering KGF with e.g. erlotinib, Iressa(TM), canertinib, or a monoclonal antibody against EGFR; side effect reduction of diarrhea, rash |
08/28/2008 | CA2678958A1 Heterocyclic aspartyl protease inhibitors |
08/27/2008 | EP1960372A1 Kinase inhibitors and their uses |
08/27/2008 | EP1960371A1 Quinazoleine derivatives used as inhibitors of erbb tyrosine kinase |
08/27/2008 | EP1960360A1 Azetidine derivatives as glyt1 inhibitors |
08/27/2008 | EP1960347A2 17-beta-hydroxysteroid dehydrogenase type 3 (17beta-hsd3) inhibitors |
08/27/2008 | EP1474146B1 Phenylpyrimidine amines as ige inhibitors |
08/27/2008 | CN101253159A Diaminopyrimidines as P2X3 and P2X2/3 modulators |
08/27/2008 | CN101253158A Process for synthesis of aryloxy diaminopyrimidines |
08/27/2008 | CN101253152A Amide derivatives as ROCK inhibitors |
08/27/2008 | CN101250162A Method for preparing agricultural weedicide |
08/27/2008 | CN100413867C 4-amino-5-phenyl-7-cyclohexyl-pyrrolo[2,3-d]pyrimidine derivatives |
08/26/2008 | US7417057 insecticides; safe for crops; Fused partially unsaturated carbocyclic or heterocyclic ring substituted with a 5-or 6-membered heterocyclic ring such as imidazole, thiazole, oxazole, 1,3,4-oxadiazole |
08/26/2008 | US7417055 Pharmacokinetics; bioavailability |
08/26/2008 | US7417048 Aryl-substituted derivatives of cycloalkyl and branched chain alkyl carboxylic acids useful as antinociceptive drugs for peripheral targets |
08/26/2008 | US7417022 Amino acid for deliverying active materials; bioavailability |
08/21/2008 | WO2008099887A1 Crystal, amorphous form and salt of methyl n-[3-(6,7-dimethoxy- 2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid |
08/21/2008 | WO2008099210A2 Piperazine derivatives for treatment of ad and related conditions |
08/21/2008 | WO2008099074A1 Phenyl- (4-phenyl-pyrimidin-2-yl) - amine derivatives as ikk inhibitors, preparation thereof, and pharmaceutical compositions thereof |
08/21/2008 | WO2008098485A1 The salts of 4-aniline quinazoline derivative |
08/21/2008 | WO2008031550A3 Nicotinic acid derivatives as modulators of metabotropic glutanate receptors |
08/21/2008 | US20080200533 Creating modified complex molecules having reduced toxicity and enhanced bioavailability; such as reaction product of atorvastatin and 2,6-diaminohexanoic acid; increasing solubility; reducing dosage levels |
08/21/2008 | US20080200478 1,7-Bis-(2,6,6-trimethylcyclohex-1-en-1-yl)-1 (E)-heptadiene-3,5-dione, analogs and derivatives thereof for treating cancer; potent inhibitory effect on the proliferation of human promyelocyte leukemia HL-60 cells |
08/21/2008 | US20080200461 Use as agricultural pesticide, fungicide, herbicide, also a pharmaceutical, for treating obesity, metabolic syndrome, atherosclerosis, cardiovascular disease and insulin resistance, diabetes, fungal infections; compounds are diamines or derivatives, with at least one tert-amine or quaternary ammonium |
08/21/2008 | US20080200445 Heterocyclic aspartyl protease inhibitors |
08/21/2008 | US20080199726 Blue emitting, durable, organoelectroluminescent layers containing pyrimidine moieties; full color displays; light emission efficiency and brightness |
08/21/2008 | US20080199454 Caspase inhibitor prodrugs |
08/21/2008 | US20080197084 Emulsion polymerization; oil industry |
08/21/2008 | CA2678477A1 Crystal, amorphous form and salt of methyl n-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid |
08/21/2008 | CA2677978A1 Salts forms of 4-phenylamino quinazoline derivative |
08/21/2008 | CA2676715A1 Piperazine derivatives for treatment of ad and related conditions |
08/21/2008 | CA2673532A1 New phenyl-(4-phenyl-pyrimidin-2-yl)-amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors |
08/20/2008 | EP1957499A1 4-anilino-substituted quinazoline derivatives as tyrosine kinase inhibitors |
08/20/2008 | EP1957469A1 Antiproliferative pyrimidyl, fused pyrimidyl and pyrimidyl hydrazones |
08/20/2008 | EP1957468A2 Polyalkylene glycol derivatives of 4 - (phenylamino)quinazolines useful as irreversible inhibitors of epidermal growth factor receptor tyrosine kinase |
08/20/2008 | EP1957467A2 Spirocyclic derivatives |
08/20/2008 | EP1957466A1 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer |
08/20/2008 | EP1957462A2 Novel 2-amino-heterocycles udeful in the treatment of abeta-related pathologies |
08/20/2008 | EP1957461A1 Bisamide inhibitors of hedgehog signaling |
08/20/2008 | EP1957459A2 Iminopropene compound and use thereof |
08/20/2008 | EP1957448A1 Substituted azacycloalkanes useful for treating cns conditions |
08/20/2008 | EP1337251B1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors |
08/20/2008 | EP1249233B1 Npyy5 antagonists |
08/20/2008 | CN101248051A Process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino benzonitrile |
08/20/2008 | CN101248050A Organic compounds |
08/20/2008 | CN101245051A 2,4-di-substituted amido-6-substituted-[1,3,5]triazine or miazines compound, preparation method, pharmaceutical combination and use of the same |
08/20/2008 | CN101245050A 4-aniline quinazoline derivative salt |
08/20/2008 | CN100412066C Compounds and compositions as protein kinase inhibitors |
08/20/2008 | CN100412065C 4-(p-fluorophenyl)-6-isopropyl-2-methylaminopyrimidine-5-methyl formate synthesis method |
08/20/2008 | CN100412064C Malononitrile compounds and its use |
08/20/2008 | CN100411515C Difluoromethanesulfonyl anilide derivatives useful as herbicides |
08/19/2008 | US7414138 e.g. 2-cyano-3-{4-[5-tert.-butyl-benzoxazol-2-yl]-phenyl}-acrylic acid 2-ethylhexyl ester; protecting human skin or human hair, and plastic material or a medicinal product that is sensitive to UV radiation from UV-A irradiation; antiaging |
08/19/2008 | US7414058 Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders |
08/19/2008 | US7414045 Substituted pyrimido[1,2-a]azepines useful as HIV integrase inhibitors |
08/19/2008 | US7414011 Pyridine, pyrimidine or triazine derivatives; selectivity; safe for agricultural plants including transgenics; synthesis |
08/19/2008 | US7413727 Contrast agents |
08/19/2008 | CA2200871C Aniline derivatives |
08/19/2008 | CA2151801C 3'-modified oligonucleotide derivatives |
08/14/2008 | WO2008097468A2 Selective endothelin type-a antagonists |
08/14/2008 | WO2008096257A1 An improved process for preparation of rosuvastatin calcium |
08/14/2008 | WO2008096145A1 Process for the preparation of ethyl-n-(2, 3-dichloro-6-nitrobenzyl) glycine hydrochloride |
08/14/2008 | WO2008095847A1 Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof |
08/14/2008 | WO2008077885A3 2- [(phenylamino) -pyrimidin-4ylamin0] -cyclopentane carboxamide derivatives and related compounds as inhibitors of kinases of the cell cycle for the treatment of cancer |